Evidence map›Paper›PMID 33958642›Full record

ArticleScientific reports2021

IgE-activated mast cells enhance TLR4-mediated antigen-specific CD4

Binh L Phong, Shaina J D'Souza, Robin L Baudier, Eric Wu, Victoria E Immethun, David L Bauer, James B McLachlan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. CD4Nature communications · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. The Effects ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Binh L Phong *Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA.
Shaina J D'Souza *Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA.
Robin L BaudierDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Eric WuDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA.
Victoria E ImmethunDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA.
David L BauerDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA.
James B McLachlanDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA. jmclachl@tulane.edu.
Tulane University · US

Funding

Mast cell control of endogenous, antigen-specific CD4 T cell immunityR21AI122197 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI MCLACHLAN, JAMES B · 2016 to 2017
$414k
NIAID NIH HHS R21 AI122197
6 · The paper itself

Abstract

Mast cells are potent mediators of allergy and asthma, yet their role in regulating adaptive immunity remains ambiguous. On the surface of mast cells, the crosslinking of IgE bound to FcεRI by a specific antigen recognized by that IgE triggers the release of immune mediators such as histamine and cytokines capable of activating other immune cells; however, little is known about the mast cell contribution to the induction of endogenous, antigen-specific CD4

Indexed as

AnimalsCD4 AntigensCD4-Positive T-LymphocytesImmunoglobulin ELipopolysaccharidesMast CellsMiceMice, Inbred C57BLToll-Like Receptor 4CD4 AntigensImmunoglobulin ELipopolysaccharidesTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID33958642
PMCPMC8102524
OpenAlexW3158205785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.